Heterocyclic compounds capable of activating STING

US12065427B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Sebastian CAROTTA · Wien, AT
• Georg Dahmann · Biberach an der Riß, DE
• Cédrickx GODBOUT · Biberach an der Riß, DE
• Sandra Handschuh · Biberach an der Riß, DE
• Herbert Nar · Ochsenhausen, DE
• Thorsten Oost · Biberach an der Riß, DE
• Ulrich Reiser · Wien, AT
• Matthias Treu · Wien, AT

Key dates

• Filing date: Apr 27, 2022
• Grant date: Aug 20, 2024
• Expiry date: Apr 27, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D495/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to heterocyclic compounds of formula (I) capable of activating STING (Stimulator of Interferon Genes).